Fact sheet: Polar Capital Healthcare Opp

Fund information

Fund name
Polar Capital Healthcare Opportunities I GBP
Fund company manager
Polar Capital
Fund type
SIB
Fund manager(s)
Gareth Powell
since 30/11/2007
Daniel Mahony
since 30/11/2007
Fund objective
The Fund aims to preserve capital and achieve long-term growth by investing in a globally-diversified portfolio of companies within the healthcare industry.
Benchmark
MSCI ACWI Health Care Index
Investment style
Active,Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

9.53 %

1 Year rank in sector

22/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.5 b

FE Risk score

146

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    79.34%
  • UK
    7.07%
  • Germany
    5.86%
  • Switzerland
    5.44%
  • Sweden
    2.01%
  • Biotechnology/Medical
    30.38%
  • Pharmaceuticals
    26.98%
  • Health Care
    25.36%
  • Healthcare & Medical Products
    17.61%
  • Money Market
    -0.32%
  • US Equities
    78.7%
  • UK Equities
    7%
  • German Equities
    5.9%
  • Swiss Equities
    5.4%
  • Swedish Equities
    2%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund1.85 %-0.25 %11.98 %31.94 %159.71 %
Sector3.92 %2.63 %16.43 %11.58 %97.05 %
Rank within sector25 / 3124 / 3122 / 304 / 271 / 23
Quartile th4 th4 th3 rd1 st1 st

Calendar performance

YTD-20182017201620152014
Fund2.86 %13.56 %4.59 %13.39 %34.81 %
Sector4.05 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector25 / 3121 / 305 / 307 / 2711 / 24
Quartile th4 th3 rd1 st2 nd2 nd

Risk statistics

Alpha8.11
Beta0.68
Sharpe0.47
Volatility14.59
Tracking error11.57
Information ratio0.57
R-Squared0.5

Price movement

52 week high32.74
52 week low27.87
Current bid price0
Current offer price0
Current mid price31.97

Holdings by region

  • 79.34% USA
  • 7.07% UK
  • 5.86% Germany
  • 5.44% Switzerland
  • 2.01% Sweden
  • 0.61% Canada
  • -0.32% Money Market

Holdings by sector

  • 30.38% Biotechnology/Medical
  • 26.98% Pharmaceuticals
  • 25.36% Health Care
  • 17.61% Healthcare & Medical Products
  • -0.32% Money Market

Holdings by asset type

  • 78.7% US Equities
  • 7% UK Equities
  • 5.9% German Equities
  • 5.4% Swiss Equities
  • 2% Swedish Equities
  • 0.7% Canadian Equities
  • 0.3% Money Market

Individual holdings

  • 9.31% JOHNSON & JOHNSON
  • 5.44% NOVARTIS AG
  • 4.19% UNITEDHEALTH GROUP INC
  • 3.8% BAYER AG
  • 3.37% NEKTAR THERAPEUTICS
  • 3.22% HUMANA INC
  • 3.11% PUMA BIOTECHNOLOGY INC
  • 3.07% ALNYLAM PHARMACEUTICALS INC
  • 3.06% BIO RAD LABORATORIES INC
  • 2.92% STRYKER CORP